Cumulus Neuroscience Presents Data At AD/PDTM 2025 Annual Meeting
Validation data presented at the 2025 Alzheimer's & Parkinson's Diseases (AD/PD) Conference confirms two novel NeuLogiq® Platform endpoints show g ...
Cumulus Neuroscience Presents Data at AD/PD 2025 Annual Meeting
Validation data presented at the 2025 Alzheimer's & Parkinson's Diseases (AD/PD) Conference confirms two novel NeuLogiq® Platform endpoints show greater separation with Alzheimer's pTau217 pathology ...
Cumulus Neuroscience Presents Data at AD/PD™ 2025 Annual Meeting
Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical ...